Evaluating a Wireless NIRS Device in the Neonatal Intensive Care Unit
1 other identifier
interventional
20
1 country
1
Brief Summary
The wireless NIRS sensor will be placed on the participant's forehead, directly underneath the INVOS wired sensor. The wireless NIRS sensor will remain in place for 4 consecutive hours, over 2 consecutive days. As standard-of-care, nursing personnel removes all sensors at every care to evaluate skin and reduce the risk of pressure sores. The wireless NIRS device will be removed and reapplied at the same time, by the research team who will annotate what time the sensor was removed, replaced, and the condition of the skin. This will be used to correlate signal disconnection with sensor care (i.e., skin checks, sensor removal, etc.).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 15, 2025
CompletedFirst Submitted
Initial submission to the registry
May 5, 2026
CompletedFirst Posted
Study publicly available on registry
July 28, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
ExpectedJuly 28, 2026
July 1, 2026
9 months
May 5, 2026
July 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Comparison of rStO2, data between the wireless NIRS and gold-standard wired NIRS.
Comparison of rStO2, data between the wireless NIRS and gold-standard wired NIRS.
6 months
Secondary Outcomes (3)
Comparison of SpO2 and Heart Rate (HR) data between the wireless NIRS and gold-standard wired vital sign monitoring system (Philips IntelliVue MX800).
6 months
Comparison of derived Heart Rate Variability (HRV) between the wireless NIRS and gold-standard wired vital sign monitoring system (Philips IntelliVue MX800).
6 months
Provide a questionnaire to capture the perspectives of clinicians and patients' parents/guardians regarding use of the wireless NIRS compared to wired NIRS device.
6 months
Study Arms (1)
Wireless Near-infrared spectroscopy (NIRS)
OTHERWireless NIRS applied to participant's forehead.
Interventions
Wireless NIRS applied to participant forehead.
Eligibility Criteria
You may qualify if:
- Infants admitted to the NICU with a gestational age of ≥ 32 weeks at the time of the monitoring
- undergoing monitoring with the INVOS wired NIRS system.
You may not qualify if:
- Infants with a skin abnormality that would potentially increase the risk of injury,
- Patient too unstable or family experiencing too much stress as determined by an attending physician or bedside care team to not be approached for recruitment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Montreal Children's Hospital
Montreal, Quebec, H3H2R9, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Guilherme Sant'Anna, MD, PhD
RI-MUHC
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Neonatologist
Study Record Dates
First Submitted
May 5, 2026
First Posted
July 28, 2026
Study Start
November 15, 2025
Primary Completion
August 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
July 28, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share